CRISPR RNA–guided activation of endogenous human genes ML Maeder, SJ Linder, VM Cascio, Y Fu, QH Ho, JK Joung Nature methods 10 (10), 977-979, 2013 | 1545 | 2013 |
Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins ML Maeder, JF Angstman, ME Richardson, SJ Linder, VM Cascio, ... Nature biotechnology 31 (12), 1137-1142, 2013 | 599 | 2013 |
Extreme vulnerability of IDH1 mutant cancers to NAD+ depletion K Tateishi, H Wakimoto, AJ Iafrate, S Tanaka, F Loebel, N Lelic, ... Cancer cell 28 (6), 773-784, 2015 | 444 | 2015 |
Unique genetic and survival characteristics of invasive mucinous adenocarcinoma of the lung HS Shim, Z Zheng, M Liebers, YJ Cha, QH Ho, M Onozato, LP Le, ... Journal of Thoracic Oncology 10 (8), 1156-1162, 2015 | 189 | 2015 |
Myc-driven glycolysis is a therapeutic target in glioblastoma K Tateishi, AJ Iafrate, Q Ho, WT Curry, TT Batchelor, KT Flaherty, ... Clinical Cancer Research 22 (17), 4452-4465, 2016 | 147 | 2016 |
Highly multiplexed fluorescence in situ hybridization for in situ genomics ML Onozato, C Yapp, D Richardson, T Sundaresan, V Chahal, J Lee, ... The Journal of Molecular Diagnostics 21 (3), 390-407, 2019 | 18 | 2019 |
NT-33 NAD+ SYNTHESIS INHIBITION AS A THERAPEUTIC STRATEGY FOR GLIOBLASTOMA WITH MYC AMPLIFICATION K Tateishi, N Lelic, QH Ho, S Esakl, JA Iafrate, DP Cahill, AS Chi, ... Neuro-Oncology 16 (suppl_5), v165-v166, 2014 | | 2014 |
Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins J Costello, ML Maeder, JF Angstman, ME Richardson, SJ Linder, ... | | 2013 |
Targeted DNA Demethylation and Endogenous Gene Activation with Programmable TALE-TET1 Proteins ML Maeder, JF Angstman, ME Richardson, SJ Linder, V Cascio, SQ Tsai, ... Engineered DNA-Binding Proteins for Targeted Genome Editing and Gene …, 2013 | | 2013 |
PATHWAY DISCOVERY IN GLIOBLASTOMA THERAPEUTIC RESISTANCE INDUCED BY COMBINATORIAL TRANSCRIPTION FACTORS R Narayanan, QH Ho, BS Levin, ML Maeder, JK Joung, CL Nutt, DN Louis NEURO-ONCOLOGY 14, 94-94, 2012 | | 2012 |